Classes
- Clinical 10 days - Department of Oncology +1D0110ONK | Second Faculty of Medicine
- Clinical Radiotherapy +1D0503007 | Second Faculty of Medicine
- Radiotherapy +1D0505002 | Second Faculty of Medicine
- Clinical Radiotherapy - Training +1D0505009 | Second Faculty of Medicine
- OS - Selected chapters from oncologyDVA1099 | Second Faculty of Medicine
Publications
- Prevention, diagnosis and treatment of cancer-associated thromboembolism2023 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- The possibilities of molecular testing of somatic aberrations in tumor tissue using NGS in routine practice - current situation in the Czech Republic2021 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Proton pencil-beam scanning radiotherapy in the treatment of nasopharyngeal cancer: dosimetric parameters and 2-year results2021 | First Faculty of Medicine, Third Faculty of Medicine
- Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes2021 | Central Library of Charles University, Third Faculty of Medicine
- A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)2021 | Publication without faculty affiliation
- Regorafenib for metastatic colorectal cancer: An analysis of a registry-based cohort of 555 patients2020 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Association of triple positivity with prognostic parameters and overall survival in a population-based study of 6,122 HER2-positive breast cancer patients: analysis of real-world clinical practice based on a research database2020 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results2019 | First Faculty of Medicine, Third Faculty of Medicine
- Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study2019 | Publication without faculty affiliation
- Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial2019 | Publication without faculty affiliation
Loading network view...